2. Academic Validation
  3. Hydroxychloroquine reduces metastatic tumor burden in pancreatic adenocarcinoma through myeloperoxidase inhibition

Hydroxychloroquine reduces metastatic tumor burden in pancreatic adenocarcinoma through myeloperoxidase inhibition

  • J Inflamm (Lond). 2025 Aug 12;22(1):33. doi: 10.1186/s12950-025-00456-8.
Britney Niemann 1,  Pavan Rao 1,  Quinn Hopen 2,  Kaitlyn Landreth 2,  Angisha Basnet 2,  Werner Geldenhuys 3 4,  Tracy W Liu 2 5,  Brian A Boone 6 7 8
Affiliations

Affiliations

  • 1 Department of Surgery, Division of Surgical Oncology, West Virginia University, Morgantown, WV, 26506, US.
  • 2 Department of Microbiology, Immunology and Cell Biology, West Virginia University, Morgantown, WV, 26506, US.
  • 3 Pharmaceutical Sciences, West Virginia University, Morgantown, WV, 26506, US.
  • 4 Neuroscience, West Virginia University, Morgantown, WV, 26506, US.
  • 5 West Virginia University Cancer Institute, West Virginia University, One Medical Center Drive, PO Box 9238 HSCS, Morgantown, WV, 26506, US.
  • 6 Department of Surgery, Division of Surgical Oncology, West Virginia University, Morgantown, WV, 26506, US. brian.boone@hsc.wvu.edu.
  • 7 Department of Microbiology, Immunology and Cell Biology, West Virginia University, Morgantown, WV, 26506, US. brian.boone@hsc.wvu.edu.
  • 8 West Virginia University Cancer Institute, West Virginia University, One Medical Center Drive, PO Box 9238 HSCS, Morgantown, WV, 26506, US. brian.boone@hsc.wvu.edu.
PMID: 40797324 DOI: 10.1186/s12950-025-00456-8
Abstract

Background: Metastatic pancreatic adenocarcinoma has a 5-year survival of only 3%. Neutrophil extracellular traps are formed when neutrophils expel their intracellular contents and have been intricately linked to metastases. Hydroxychloroquine is an FDA-approved anti-malarial drug and neutrophil extracellular trap inhibitor with high potential for clinical translation. This study investigates the impact of hydroxychloroquine treatment on pancreatic metastases.

Results: Hydroxychloroquine reduced metastatic tumor burden via a neutrophil extracellular trap independent mechanism and resulted in prolonged survival. Hydroxychloroquine inhibited the function of myeloperoxidase in vitro via direct binding with a Kd of 9.74 mM. Myeloperoxidase inhibition via hydroxychloroquine in vivo was the direct result of suppressed activity. Hydroxychloroquine mediated myeloperoxidase inhibition was also demonstrated in metastatic pancreatic adenocarcinoma patients receiving neoadjuvant chemotherapy.

Conclusion: Hydroxychloroquine suppressed pancreatic metastases growth through myeloperoxidase inhibition, leading to a significant increase in survival. Corroborative data supports this mechanism in metastatic pancreatic adenocarcinoma patients treated with hydroxychloroquine. These data provide important insight into the role of myeloperoxidase in pancreatic metastases and the potential use of hydroxychloroquine in metastatic pancreatic adenocarcinoma treatment.

Keywords

Hydroxychloroquine; Metastasis; Myeloperoxidase; Pancreatic adenocarcinoma; Reactive oxygen species.

Figures
Products
嗨！很高兴为您提供帮助！

尊敬的 MCE 客户您好，
请您选择所在区域，我们将转接对应客服为您服务！

热门区域

A

B

C

F

G

H

J

L

N

Q

S

T

X

Y

Z

热 A B C F G H J L N Q S T X Y Z